mHealth Intelligence November 2, 2023
New research shows that using hormone data gathered by wearable devices can help clinicians determine cancer growth and provide personalized care.
Researchers at the University of Virginia Health (UVA Health) have found that wearable devices can be used to glean insights into patients’ cortisol levels, enabling clinicians to identify and provide personalized care to at-risk cancer patients.
The research is still in its early stages, but UVA Health researchers have discovered that pancreatic cancer patients with high cortisol levels resulting from disrupted sleep will experience faster tumor growth.
Scientific literature shows that there is a robust link between cancer patients’ health behaviors and their tumor progression. Hormones associated with these behaviors, such as cortisol and melatonin, have also been found...